Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10561 - 10568 of 11617 results
Does District Court Dismissal of Declined Qui Tam Threaten Future DOJ False Claims Enforcement?
August 8, 2013| Blog| Viewpoint
Huge FCRA Verdict Against Equifax Shows Potential Costs of Failing to Protect and Correct Consumer’s Credit History
August 7, 2013| Blog| Viewpoint
New Bill Proposes to Eliminate Stark Law Exception for Certain In-Office Ancillary Services
August 7, 2013| Blog| Viewpoint
Will California Voters Move US to Opt-In?
August 6, 2013| Blog| Viewpoint
Six Flags Rollercoaster Tragedy Highlights Sometimes Confusing Nature of CPSC’s Jurisdiction
August 6, 2013| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Reform Update on August 5, 2013
August 6, 2013| Blog| Viewpoint
Massachusetts Supreme Judicial Court Bows to U.S. Supreme Court on Class Action Waivers in Arbitration Agreements
August 6, 2013| Alert| Viewpoint
FTC v. Wyndham: Wyndham Calls for Back-Up
August 5, 2013| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.